1. Home
  2. ELVN vs STAA Comparison

ELVN vs STAA Comparison

Compare ELVN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • STAA
  • Stock Information
  • Founded
  • ELVN 2016
  • STAA 1982
  • Country
  • ELVN United States
  • STAA United States
  • Employees
  • ELVN N/A
  • STAA N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • STAA Ophthalmic Goods
  • Sector
  • ELVN Health Care
  • STAA Health Care
  • Exchange
  • ELVN Nasdaq
  • STAA Nasdaq
  • Market Cap
  • ELVN 1.1B
  • STAA 1.1B
  • IPO Year
  • ELVN 2020
  • STAA N/A
  • Fundamental
  • Price
  • ELVN $22.66
  • STAA $21.71
  • Analyst Decision
  • ELVN Strong Buy
  • STAA Buy
  • Analyst Count
  • ELVN 5
  • STAA 7
  • Target Price
  • ELVN $37.80
  • STAA $42.83
  • AVG Volume (30 Days)
  • ELVN 230.9K
  • STAA 662.4K
  • Earning Date
  • ELVN 03-13-2025
  • STAA 02-19-2025
  • Dividend Yield
  • ELVN N/A
  • STAA N/A
  • EPS Growth
  • ELVN N/A
  • STAA 9.97
  • EPS
  • ELVN N/A
  • STAA 0.44
  • Revenue
  • ELVN N/A
  • STAA $341,224,000.00
  • Revenue This Year
  • ELVN N/A
  • STAA $8.37
  • Revenue Next Year
  • ELVN N/A
  • STAA $10.55
  • P/E Ratio
  • ELVN N/A
  • STAA $49.35
  • Revenue Growth
  • ELVN N/A
  • STAA 10.01
  • 52 Week Low
  • ELVN $10.90
  • STAA $21.13
  • 52 Week High
  • ELVN $30.03
  • STAA $52.68
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 46.94
  • STAA 31.80
  • Support Level
  • ELVN $20.16
  • STAA $21.13
  • Resistance Level
  • ELVN $25.37
  • STAA $25.36
  • Average True Range (ATR)
  • ELVN 1.65
  • STAA 1.18
  • MACD
  • ELVN -0.07
  • STAA -0.13
  • Stochastic Oscillator
  • ELVN 47.98
  • STAA 13.58

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: